Taken together, these findings demonstrate that blockade of PAI1 improves response to HER2 kinase inhibition across multiple HER2+ breast cancer cell lines under both conditions of direct coculture and exposure to fibroblast-conditioned medium. This evidence concerns the gene ERBB2 and breast carcinoma.